CDER - Office of Drug Evaluation III - Organization - Text version

The following header reflects the organizational hierarchy.

FOOD AND DRUG ADMINISTRATION
OFFICE OF MEDICAL PRODUCTS AND TOBACCO
CENTER FOR DRUG EVALUATION AND RESEARCH
OFFICE OF NEW DRUGS
OFFICE OF DRUG EVALUATION III

The following is the communication box containing information to assist anyone who may want to communicate with the depicted organization via telephone, facsimile or mail.

Main Tele:     301-796-2100
Fax:               301-796-9906
Address:        WO Bldg 22 Rm: 5214
                      10903 New Hampshire Ave.
                      Silver Spring, MD 20993

The following is the Food and Drug Administration, Office of Medical Products and Tobacco, Center for Drug Evaluation and Research, Office of New Drugs, Office of Drug Evaluation III organization structure depicting all the organizational structures reporting to the Office Director.  These organizational structures are organized in sequential order by their assigned Standard Administrative code (Alphanumeric sequence of characters beginning with the letter D).

Each organizational component will be depicted in the following standard format:

Title of organization.
Position title of the manager.
Military rank if any, first name, middle initial if any, last name, post graduate degrees if any, and if the individual is designated as acting.
Standard Administrative code.

DIRECTOR
Julie G. Beitz, M.D.

Reports Directly to the Director:

DEPUTY DIRECTOR
Victoria Kusiak, M.D.
(DKKNRC)

Approved by the FDA Reorganization Coordinator and Principal Delegations Control Officer